Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Feb 24, 2021, after the close
10-K filed Feb 24, 2021, 55 days after period end · 0001564590-21-008124
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|
| Revenue | $30.19M | $24.21M | — |
| Net Income | -$44.57M | -$20.61M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR